Activation of spleen lymphocytes by plasmid DNA

Vaccine

Volumn 17, Issue 9-10, 1999, Pages 1193-1200

  Rykova, Elena Yu ^a   Laktionov, Pavel P ^a   Vlassov, Valentin V ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

Author keywords

Immunoglobulins; Lymphocyte activation; Plasmid DNA

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN RECEPTOR; PLASMID DNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; IMMUNOPRECIPITATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE;

ANIMALS; CELL DIVISION; DNA; DNA-BINDING PROTEINS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN FRAGMENTS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; PLASMIDS; RABBITS; RECEPTORS, IMMUNOLOGIC; SPLEEN;

EID: 0033525786     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00340-5     Document Type: Article

References (44)

1. Tokunaga T., Yamamoto H., Shimada S.et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization and antitumor activity. J Natl Cancer Inst. 72:1984;955-962.
2. Shimada S., Yano O., Inoue H.et al. Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors. J Natl Cancer Inst. 74:1985;681-688.
3. Tokunaga T., Yano O., Kuramoto E.et al. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol Immunol. 36:1992;55-66.
4. Mojcik C.F., Gourley M.F., Klinman D.M.et al. Administration of a phosphorothioate oligonucleotide antisense to murine endogenous retroviral MCF env causes immune effects in vivo in a sequence-specific manner. Clin Immunol Immunopathol. 67:1993;130-136.
5. Branda R.F., Moore A.L., Mathews L.et al. Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1. Biochem Pharmacol. 45:1993;2037-2043.
6. McIntyre K.W., Lombard-Gillooly K., Perez J.R.et al. A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor NF-kappa B p65 causes sequence-specific immune stimulation. Antisense Res Dev. 3:1993;309-322.
7. Branda R.F., Moore A.L., Lafayette A.R.et al. Amplification of antibody production by phosphorothioate oligodeoxynucleotides. J Lab Clin Med. 128:1996;329-338.
8. Harel-Bellan A., Ferris D.K., Vincouir M.et al. Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxy-oligonucleotide in human T-lymphocytes. J Immunol. 140:1988;2431-2435.
9. Furukawa Y., Piwnica-Worms H., Ernst T.J.et al. cdc2 gene expression at the G1 to S transition in human T-lymphocytes. Science. 250:1990;805-808.
10. Gewirtz A.M., Anfossi G., Venturelli D.et al. G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. Science. 245:1989;180-183.
11. Krieg A.M., Gause W.C., Gourley M.F., Steinberg A.D. A role for endogenous retroviral sequences in the regulation of lymphocyte activation. J Immunol. 143:1989;2448-2451.
12. Krieg A.M., Yi A.-K., Matson S.et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
13. Tanaka T., Chu C.C., Paul W.E. An antisense oligonucleotide complementary to a sequence in Iγ2b increases γ2b germline transcripts, stimulates B-cell DNA synthesis and inhibits immunoglobulin secretion. J Exp Med. 175:1992;597-607.
14. Wagner R.W. Gene inhibition using antisense oligodeoxynucleotides. Nature. 372:1994;333-335.
15. Stein C., Krieg A. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res Dev. 4:1994;67-69.
16. Rykova E.Yu., Pautova L.V., Yakubov L.A.et al. Serum immunoglobulins interact with oligonucleotides. FEBS Lett. 344:1994;96-98.
17. Stein C.A., Cleary A.M., Yakubov L., Lederman S. Phosphorothioate oligodeoxynucleotides bind to the third variable loop domain (v3) of human immunodeficiency virus type 1 gp120. Antisense Res Dev. 3:1993;19-31.
18. Ecker D.J., Wyatt J.R., Vickers T.et al. Novel guanosine quartet structure binds to the HIV envelope and inhibits envelope mediated cell fusion. Nucleosides Nucleotides. 14:1995;1117-1127.
19. Beltinger C., Saragovi H.U., Smith R.M.et al. Binding, uptake and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest. 95:1995;1814-1823.
20. Hawley P., Gibson I. Interaction of oligodeoxynucleotides with mammalian cells. Antisense Nucl Acids Drug Dev. 6:1996;185-195.
21. Perez J.R., Li Y., Stein C.A.et al. Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc Natl Acad Sci USA. 91:1994;5957-5961.
22. Roman M., Martin-Orozco E., Goodman J.S. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med. 3:1997;849-854.
23. Mishenina G.F., Samukov V.V., Shubina T.N. Selective modification of monosubstituted phosphate groups in nucleoside and oligonucleotide 5′-mono- and polyphosphates. Bioorg Khim (Moskow). 5:1979;886-893.
24. Birnboim H.C., Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucl. Acids Res. 7:1979;1513-1522.
25. Aida Y., Pabst M.J. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J Immunol Meth. 132:1990;191-195.
26. Pautova L.V., Laktionov P.P., Rykova E.Yu.et al. Study of interactions of polyreactive antibodies with nucleic acids using alkylating oligonucleotide derivatives. Mol Biol (Moscow). 30:1996;559-565.
27. Lane, RD, Crissman, RS, Ginn, S In: Langone, JJ, Vanakis, HV, editors. Methods Enzymol Acadamy, London, vol. 121, 1986. p. 183-92.
28. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. Current protocols in immunology. New York: Green Publishing and Wiley Interscience, 1993. p. 6.1.7.-10.
29. Messina J.P., Gilkeson G.S., Pisetsky D.S. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol. 147:1991;1759-1764.
30. 3H ]thymidine incorporation by 'control' oligonucleotides Antisense Res Dev. 2:1992;325-330.
31. Phillips N.E., Parker D.C. Cross-linking of B-lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J Immunol. 132:1984;627-632.
32. Yuan D. Regulation of IgM and IgD synthesis in B-lymphocytes. II. Translational and posttranslational events. J Immunol. 132:1984;1566-1570.
33. Barclay AN, Birkeland ML, Brown M, Beyers AD, Davis SJ, Somoza C, Williams AF. The leucocyte antigen facts book. London: Academic, 1993. p. 405-7.
34. Pisetsky D.S., Reich C., Crowley S.D., Halpern M.D. Immunological properties of bacterial DNA. Ann NY Acad Sci. 772:1995;152-163.
35. Klinman D.M., Yi A.-K., Beaucage S.L.et al. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12 and interferon gamma. Proc Natl Acad Sci USA. 93:1996;2879-2883.
36. Li Yu.S., Dearden-Badet M.-T., Revillard J.-P. Selective induction of high levels of IgA synthesis in Peyer's patch B-cells by protein kinase C-activating phorbol esters. J Immunol. 147:1991;1752-1758.
37. Couturier C., Haeffner-Cavaillon N., Caroff M., Kazatchkine M.D. Binding sites for endotoxins (lipopolysaccharides) on human monocytes. J Immunol. 147:1991;1899-1904.
38. Hefeneider S.H., Cornell K.A., Brown L.E.et al. Nucleosomes and DNA bind to specific cell-surface molecules on murine cells and induce cytokine production. Clin Immunol Immunopathol. 63:1992;245-251.
39. Loke S.L., Stein C.A., Zhang X.et al. Characterization of oligonucleotide transport into living cells. Proc Nat Acad Sci USA. 86:1989;3474-3478.
40. Kitajima I., Shinohara T., Minor T.et al. Human T-cell leukemia virus type I tax transformation is associated with increased uptake of oligodeoxynucleotides in vitro and in vivo. J Biol Chem. 267:1992;25881-25888.
41. Gasparro F.P., Dall'Amico R., O'Malley M.et al. Cell membrane DNA: a new target for psoralen photoadduct formation. Photochem Photobiol. 52:1990;315-321.
42. Geselowitz D.A., Neckers L.M. Analysis of oligonucleotide binding, internalization and intracellular trafficking utilizing a novel radiolabeled crosslinker. Antisense Res Dev. 2:1992;17-25.
43. Bennet R.M., Kotzin B.L., Merritt M.J. DNA receptor disfunction in systemic lupus erythematosus and kindred disorders: induction by anti-DNA antibodies, antihistone antibodies and anti receptor antibodies. J Exp Med. 166:1987;850-863.
44. Kimura Y., Sonehara K., Kuramoto E.et al. Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN. Biochem. 116:1994;991-994.